217 related articles for article (PubMed ID: 36037283)
1. Lanthanide-Nucleotide Coordination Nanoparticles for STING Activation.
Luo Z; Liang X; He T; Qin X; Li X; Li Y; Li L; Loh XJ; Gong C; Liu X
J Am Chem Soc; 2022 Sep; 144(36):16366-16377. PubMed ID: 36037283
[TBL] [Abstract][Full Text] [Related]
2. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.
Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA
FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343
[TBL] [Abstract][Full Text] [Related]
3. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
[TBL] [Abstract][Full Text] [Related]
4. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.
Cheng N; Watkins-Schulz R; Junkins RD; David CN; Johnson BM; Montgomery SA; Peine KJ; Darr DB; Yuan H; McKinnon KP; Liu Q; Miao L; Huang L; Bachelder EM; Ainslie KM; Ting JP
JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429378
[TBL] [Abstract][Full Text] [Related]
5. TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.
Temizoz B; Kuroda E; Ohata K; Jounai N; Ozasa K; Kobiyama K; Aoshi T; Ishii KJ
Eur J Immunol; 2015 Apr; 45(4):1159-69. PubMed ID: 25529558
[TBL] [Abstract][Full Text] [Related]
6. A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment.
Nagata M; Kosaka A; Yajima Y; Yasuda S; Ohara M; Ohara K; Harabuchi S; Hayashi R; Funakoshi H; Ueda J; Kumai T; Nagato T; Oikawa K; Harabuchi Y; Esteban C; Ohkuri T; Kobayashi H
Cancer Immunol Immunother; 2021 Aug; 70(8):2301-2312. PubMed ID: 33507344
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration.
Wehbe M; Wang-Bishop L; Becker KW; Shae D; Baljon JJ; He X; Christov P; Boyd KL; Balko JM; Wilson JT
J Control Release; 2021 Feb; 330():1118-1129. PubMed ID: 33189789
[TBL] [Abstract][Full Text] [Related]
8. A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination.
Junkins RD; Gallovic MD; Johnson BM; Collier MA; Watkins-Schulz R; Cheng N; David CN; McGee CE; Sempowski GD; Shterev I; McKinnon K; Bachelder EM; Ainslie KM; Ting JP
J Control Release; 2018 Jan; 270():1-13. PubMed ID: 29170142
[TBL] [Abstract][Full Text] [Related]
9. Innate Immune Activation by cGMP-AMP Nanoparticles Leads to Potent and Long-Acting Antiretroviral Response against HIV-1.
Aroh C; Wang Z; Dobbs N; Luo M; Chen Z; Gao J; Yan N
J Immunol; 2017 Dec; 199(11):3840-3848. PubMed ID: 29084836
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site.
Ohkuri T; Kosaka A; Ishibashi K; Kumai T; Hirata Y; Ohara K; Nagato T; Oikawa K; Aoki N; Harabuchi Y; Celis E; Kobayashi H
Cancer Immunol Immunother; 2017 Jun; 66(6):705-716. PubMed ID: 28243692
[TBL] [Abstract][Full Text] [Related]
11. STING activation in cancer immunotherapy.
Su T; Zhang Y; Valerie K; Wang XY; Lin S; Zhu G
Theranostics; 2019; 9(25):7759-7771. PubMed ID: 31695799
[TBL] [Abstract][Full Text] [Related]
12. Submicron-sized hydrogels incorporating cyclic dinucleotides for selective delivery and elevated cytokine release in macrophages.
Lee E; Jang HE; Kang YY; Kim J; Ahn JH; Mok H
Acta Biomater; 2016 Jan; 29():271-281. PubMed ID: 26485167
[TBL] [Abstract][Full Text] [Related]
13. STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice.
Skouboe MK; Knudsen A; Reinert LS; Boularan C; Lioux T; Perouzel E; Thomsen MK; Paludan SR
PLoS Pathog; 2018 Apr; 14(4):e1006976. PubMed ID: 29608601
[TBL] [Abstract][Full Text] [Related]
14. An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases.
Liu Y; Crowe WN; Wang L; Lu Y; Petty WJ; Habib AA; Zhao D
Nat Commun; 2019 Nov; 10(1):5108. PubMed ID: 31704921
[TBL] [Abstract][Full Text] [Related]
15. A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy.
Luo T; Nash GT; Jiang X; Feng X; Mao J; Liu J; Juloori A; Pearson AT; Lin W
Adv Mater; 2022 Sep; 34(39):e2110588. PubMed ID: 35952624
[TBL] [Abstract][Full Text] [Related]
16. Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy.
Shae D; Becker KW; Christov P; Yun DS; Lytton-Jean AKR; Sevimli S; Ascano M; Kelley M; Johnson DB; Balko JM; Wilson JT
Nat Nanotechnol; 2019 Mar; 14(3):269-278. PubMed ID: 30664751
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled cGAMP-STINGΔTM signaling complex as a bioinspired platform for cGAMP delivery.
He Y; Hong C; Yan EZ; Fletcher SJ; Zhu G; Yang M; Li Y; Sun X; Irvine DJ; Li J; Hammond PT
Sci Adv; 2020 Jun; 6(24):eaba7589. PubMed ID: 32582856
[TBL] [Abstract][Full Text] [Related]
18. STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways.
Johnson BM; Uchimura T; Gallovic MD; Thamilarasan M; Chou WC; Gibson SA; Deng M; Tam JW; Batty CJ; Williams J; Matsushima GK; Bachelder EM; Ainslie KM; Markovic-Plese S; Ting JP
J Immunol; 2021 May; 206(9):2015-2028. PubMed ID: 33820855
[TBL] [Abstract][Full Text] [Related]
19. Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase (cGAS), a Multifaceted Platform of Intracellular DNA Sensing.
Verrier ER; Langevin C
Front Immunol; 2021; 12():637399. PubMed ID: 33708225
[TBL] [Abstract][Full Text] [Related]
20. Activation of STING signaling accelerates skin wound healing.
Mizutani Y; Kanbe A; Ito H; Seishima M
J Dermatol Sci; 2020 Jan; 97(1):21-29. PubMed ID: 31813660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
